Showing 3021-3040 of 8875 for: Cochrane Systematic Reviews Back
- Fundal pressure versus controlled cord traction as part of the active management of the third stage of labour
Cochrane Systematic Reviews, 17-Oct-2007
There are two basic interventions to help to deliver the placenta as part of the active management of the third stage of labour: (1) fundal pressure, and (2) controlled traction on the umbilical cord. Both of these methods may, in addition, have adverse o
- Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia
Cochrane Systematic Reviews, 8-Dec-2022
Laparoscopic Heller’s cardiomyotomy (LHC) is the preferred treatment of achalasia. It improves dysphagia by dividing muscles of the lower oesophageal sphincter, but this intervention can result in debilitating gastro-oesophageal reflux symptoms in some pa
- Fundoplication versus postoperative medication for gastro‐oesophageal reflux in children with neurological impairment undergoing gastrostomy
Cochrane Systematic Reviews, 28-Aug-2013
Children with neurological impairments frequently experience feeding difficulties, which can lead to malnutrition and growth failure. Gastrostomy feeding is now the preferred method of providing nutritional support to children with neurological impairment
- Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus
Cochrane Systematic Reviews, 23-Jul-2001
Inhibition of prostaglandin synthesis mediates closure of the ductus arteriosus and renal side effects after indomethacin administration. Because furosemide increases prostaglandin production, it could potentially help prevent indomethacin-related toxicit
- Gabapentin add‐on treatment for drug‐resistant focal epilepsy
Cochrane Systematic Reviews, 12-Jan-2021
This is an updated version of the Cochrane Review previously published in 2018.
- Gabapentin for chronic neuropathic pain in adults
Cochrane Systematic Reviews, 9-Jun-2017
Gabapentin is commonly used to treat neuropathic pain (pain due to nerve damage). This review updates a review published in 2014, and previous reviews published in 2011, 2005 and 2000.
- Gabapentin for fibromyalgia pain in adults
Cochrane Systematic Reviews, 3-Jan-2017
This review replaces part of an earlier review that evaluated gabapentin for both neuropathic pain and fibromyalgia, now split into separate reviews for the two conditions. This review will consider pain in fibromyalgia only.
- Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults
Cochrane Systematic Reviews, 24-Jun-2013
Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane
- Galactomannan detection for invasive aspergillosis in immunocompromised patients
Cochrane Systematic Reviews, 30-Dec-2015
Invasive aspergillosis is the most common life-threatening opportunistic invasive mycosis in immunocompromised patients. A test for invasive aspergillosis should neither be too invasive nor too great a burden for the already weakened patient. The serum ga
- Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
Cochrane Systematic Reviews, 20-May-2019
Invasive aspergillosis (IA) is a life-threatening opportunistic mycosis that occurs in some people with a compromised immune system. The serum galactomannan enzyme-linked immunosorbent assay (ELISA) rapidly gained widespread acceptance as part of the diag
- Galantamine for Alzheimer's disease and mild cognitive impairment
Cochrane Systematic Reviews, 25-Jan-2006
Galantamine is a specific, competitive, and reversible acetylcholinesterase inhibitor.
- Galantamine for dementia in people with Down syndrome
Cochrane Systematic Reviews, 21-Jan-2009
Alzheimer's dementia (AD) is the most common form of dementia in people with Down Syndrome (DS). Acetylcholine is a chemical found in the brain that has an important role in memory, attention, reason and language. Galantamine both inhibits the activity of
- Galantamine for vascular cognitive impairment
Cochrane Systematic Reviews, 25-Jan-2006
Vascular dementia represents the second most common type of dementia after that caused by Alzheimer's disease. Particularly in older patients, the combination of vascular dementia and Alzheimer's disease is common and is referred to as mixed dementia. The
- Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 9-Jan-2017
Imbalance of gamma aminobutyric acid (GABA) and related modulators has been implicated as an important factor in the pathogenesis of amyotrophic lateral sclerosis (ALS), which is also known as motor neuron disease (MND). In this context, the role and mech
- Gamma aminobutyric acid (GABA) receptor agonists for acute stroke
Cochrane Systematic Reviews, 30-Oct-2018
Gamma aminobutyric acid (GABA) receptor agonists have been shown to have a neuroprotectant effect in reducing infarct size and improving functional outcome in animal models of cerebrovascular disease. However, the sedative effects of GABA receptor agonist
- Gamma‐aminobutyric acid agonists for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 17-Apr-2018
Chronic antipsychotic drug treatment may cause tardive dyskinesia (TD), a long-term movement disorder. Gamma-aminobutyric acid (GABA) agonist drugs, which have intense sedative properties and may exacerbate psychotic symptoms, have been used to treat TD.
- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
Cochrane Systematic Reviews, 17-Feb-2010
Chronic excessive alcohol consumption may lead to dependence, and to alcohol withdrawal syndrome (AWS) in case of abrupt drinking cessation. Gamma-hydroxybutyric acid (GHB) can prevent and suppress withdrawal symptoms, and improve the medium-term abstinen
- Gangliosides for acute ischaemic stroke
Cochrane Systematic Reviews, 23-Oct-2001
Gangliosides may have a protective effect on the central and peripheral nervous systems.
- Gangliosides for acute spinal cord injury
Cochrane Systematic Reviews, 20-Apr-2005
Spinal cord injury (SCI) results in loss of feeling and movement. The consequences can be devastating for the patient and his or her carers. Global estimates of the number of new cases annually range from 15 to 40 per million. Leading causes of acute SCI
- Ganoderma lucidum (Reishi mushroom) for cancer treatment
Cochrane Systematic Reviews, 5-Apr-2016
Ganoderma lucidum is a natural medicine that is widely used and recommended by Asian physicians and naturopaths for its supporting effects on immune system. Laboratory research and a handful of preclinical trials have suggested that G. lucidum carries pro
